Effect of central angiotensin II on body weight gain in young rats.

Brain Res

Department of Physiology and Developmental Biology and the Neuroscience Center, Brigham Young University, Provo, UT 84602, USA.

Published: January 2003

Systemic infusion of ANG II decreases body weight and food intake and increases energy expenditure. We recently reported that young rats receiving a 1-week intracerebroventricular (i.c.v.) infusion of angiotensin II (ANG II) exhibited decreased body weight compared to control. The aim of the present investigation was to determine if chronic i.c.v. infusion of ANG II also decreases food intake and increases energy expenditure. Young rats were infused with i.c.v. 0.9% saline or ANG II (16.7 or 4.2 ng/min) for at least 10 days and body weight and food intake were monitored daily. Pair-fed rats had the same daily food intake as the ANG II-infused rats. The i.c.v. ANG II decreased body weight gain and food intake. The decrease in weight gain was greater than in the pair-fed groups. The expression of mRNA for uncoupling protein-1 (UCP-1) in BAT was increased significantly in the ANG II-infused rats compared to the pair-fed animals. Subcutaneous infusion of ANG II at the same doses used for i.c.v. infusion had no effect on body weight or food intake. The expression of CRH mRNA in the paraventricular nucleus was not increased in the ANG II-infused rats. These data are consistent with the idea that i.c.v. ANG II decreases body weight gain in young rats, in part, by decreasing food intake and, in part, by increasing thermogenesis (although via a CRH-independent mechanism). This central effect of ANG II may contribute to or complement the effect of peripheral ANG II on body weight.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0006-8993(02)03676-4DOI Listing

Publication Analysis

Top Keywords

body weight
32
food intake
28
weight gain
16
young rats
16
ang
12
infusion ang
12
ang decreases
12
weight food
12
icv infusion
12
ang ii-infused
12

Similar Publications

Introduction: This report provides prevalence estimates of adult obesity and severe obesity during August 2021-August 2023 by age and sex, as well as obesity prevalence by education level. Trends in the prevalence of adult obesity and severe obesity over the previous 10 years are also shown.

Methods: Data from the August 2021-August 2023 National Health and Nutrition Examination Survey (NHANES) were used for prevalence estimates, incorporating examination survey sample weights into the analysis and accounting for the survey's complex, multistage probability design.

View Article and Find Full Text PDF

Glyphosate exposure and GM seed rollout unequally reduced perinatal health.

Proc Natl Acad Sci U S A

January 2025

Department of Economics, University of Oregon, Eugene, OR 97403.

The advent of herbicide-tolerant genetically modified (GM) crops spurred rapid and widespread use of the herbicide glyphosate throughout US agriculture. In the two decades following GM-seeds' introduction, the volume of glyphosate applied in the United States increased by more than 750%. Despite this breadth and scale, science and policy remain unresolved regarding the effects of glyphosate on human health.

View Article and Find Full Text PDF

Objectives: Maternal occupational exposures during early pregnancy can be detrimental to foetus health and have short- and long-term health effects on the child. This study examined their association with adverse birth outcomes.

Methods: The study included 3938 nulliparous women from the Italian NINFEA mother-child cohort.

View Article and Find Full Text PDF

Walking patterns can differ between children and adults, both kinematically and kinetically. However, the detailed nature of the ankle pattern has not been clarified. We investigated musculature, biomechanics, and muscle activation strategies and their relevance to walking performance in preschool (PS) and school children (SC), with adults (AD) as reference.

View Article and Find Full Text PDF

Unlabelled: Insulin-like growth factor 1 (IGF-1) is the main mediator of fetal growth. An association has been described between low levels of IGF-1 and the development of some morbidities such as bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) in newborns weighing less than 1500 grams or less than 32 weeks at birth.

Objective: To determine the association between serum levels of IGF-1 and morbidity in premature infants.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!